Pharmacy benefit managers, which serve as the middlemen between drug makers, insurers and pharmacies, reaped $7.3 billion in revenue from marking up the prices of dozens of specialty generic drugs ...

January is a big time for drugmakers to hike prices. This year saw higher prices for 575 medications so far, including ...

Popular diabetes drugs such as Ozempic and Trulicity are among 25 drugs Medicare has spent the most on but hasn't yet ...

A review of the FDA’s drug approvals of 2024 shows that small companies loomed large—both in the sheer number of nods g | ...

CVS Caremark, Express Scripts and OptumRx dramatically mark up specialty generic drugs to affiliated pharmacies, the Federal ...

Findings show the impact of drug companies’ relentless price increases, underscoring the importance of the changes included ...

AARP’s new research finds price growth for top Part D prescription drugs has exceeded inflation, making a case for allowing ...